Emami share price
NSE: EMAMILTDBSE: 531162Personal ProductsSmall Cap
Emami Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1995 on BSE, Aug 2006 on NSE
Last close ₹368.90up ₹2.60 (0.71%)BSE ₹370.80
Share price at the NSE close on 27 Oct 2026. Previous close ₹366.30.
27 Oct: open ₹366.65, high ₹377.00, low ₹365.55
52-week range of traded prices to 27 Oct 2026
₹361.15Low, 1 Sep 2026₹556.15High, 28 Oct 2025
- Next results date: the board meets on 5 Nov 2026 to consider: financial results, dividend and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,833 Cr349th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 21.16
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.71%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 26.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 26.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.04
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 14,62,60263.4% delivered
About Emami
Emami Limited manufactures and markets personal care and healthcare products. Its portfolio has over 550 products, and its brands include Navratna, BoroPlus, Smart And Handsome, Zandu Balm, Mentho Plus, Kesh King, Dermicool and 7 Oils in One.
The business is split into a domestic business and an international business. The domestic business is reported in categories that include Hair and Scalp Care, Skin Care, Health Care and Strategic Investments. The Strategic Investments category covers newer brands, among them The Man Company, Brillare and Axiom Ayurveda.
In India, its products are available across more than 5.4 million retail outlets through over 3,400 distributors. It has manufacturing units at Vapi in Gujarat, Masat in Dadra and Nagar Haveli, Pantnagar in Uttarakhand, and Pacharia and Amingaon in Assam. Internationally, it has a presence in over 70 countries across SAARC, MENAP, SEA, Africa, Eastern Europe and CIS regions.
It was incorporated in 1983, and its registered office is in Kolkata. It acquired Zandu Pharmaceutical Works Ltd. in 2008, the Kesh King hair and scalp care brand in 2015, Creme 21, a German skincare brand, in 2019, and Dermicool in 2022. In the quarter to June 2026, it increased its stake in Axiom Ayurveda to make it a wholly owned subsidiary and acquired a majority stake in IncNut. Emami Limited is the flagship company of the Emami Group.
Written from the annual report for the year to Mar 2026, filed 30 Jul 2026 and the investor presentation.
Sources for 23 statements, each with its page
- Manufactures and markets personal care and healthcare products; portfolio of over 550 products. Investor presentation, page 3
- Brands include Navratna, BoroPlus, Smart And Handsome, Zandu Balm, Mentho Plus, Kesh King, Dermicool, 7 Oils in One. Investor presentation, page 3
- Business has a domestic business and an international business. Investor presentation, page 2
- Domestic business includes a Hair and Scalp Care category. Investor presentation, page 2
- Domestic business includes Skin Care and Health Care categories. Investor presentation, page 2
- Domestic business includes a Strategic Investments category. Investor presentation, page 2
- The Man Company, Brillare and Axiom Ayurveda are strategic investments that are now subsidiaries. Investor presentation, page 4
- Products are available across more than 5.4 million retail outlets in India through over 3,400 distributors. Investor presentation, page 4
- Has manufacturing units. Annual report, page 27
- Manufacturing unit at Vapi, Gujarat. Annual report, page 27
- Manufacturing unit at Masat, Dadra and Nagar Haveli. Annual report, page 27
- Manufacturing unit at Pantnagar, Uttarakhand. Annual report, page 27
- Manufacturing units at Pacharia and Amingaon, Assam. Annual report, page 27
- Presence in over 70 countries across SAARC, MENAP, SEA, Africa, Eastern Europe and CIS. Investor presentation, page 4
- Incorporated in 1983 (year in the CIN). Annual report, page 2
- Registered office is in Kolkata. Annual report, page 2
- Acquired Zandu Pharmaceutical Works Ltd. in 2008. Investor presentation, page 4
- Acquired Kesh King in 2015. Investor presentation, page 4
- Acquired Creme 21, a German skincare brand, in 2019. Investor presentation, page 4
- Acquired Dermicool in 2022. Investor presentation, page 4
- Increased stake in Axiom Ayurveda, making it a wholly owned subsidiary, in the quarter to June 2026. Investor presentation, page 2
- Acquired a majority stake in IncNut in the quarter to June 2026. Investor presentation, page 2
- Emami Limited is the flagship company of the Emami Group. Investor presentation, page 4
Results
Consolidated; ₹ crore.Emami quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +2.8%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- −8.5%
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1,039 Crup 12.33%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹139 Crdown 2.95%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 13.4%
Revenue by quarter
Peak revenue ₹1,152 Cr, quarter to Dec 2025; lowest ₹799 Cr, quarter to Sep 2025
Net profit by quarter, a loss in red
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 891 | 1,049 | 963 | 904 | 799 | 1,152 | 925 | 1,039 |
| Net profit | 211 | 279 | 162 | 164 | 148 | 319 | 143 | 139 |
| Net margin | 23.7% | 26.6% | 16.8% | 18.2% | 18.6% | 27.7% | 15.5% | 13.4% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹3,780 Crdown 0.78%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹775 Crdown 3.42%
- Net margin
- 20.5%
Revenue by year
Peak revenue ₹3,809 Cr, year to Mar 2025; lowest ₹2,533 Cr, year to Mar 2017
Net profit by year, a loss in red
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,533 | 2,541 | 2,693 | 2,655 | 2,881 | 3,192 | 3,406 | 3,578 | 3,809 | 3,780 |
| Net profit | 340 | 306 | 303 | 302 | 455 | 837 | 627 | 724 | 803 | 775 |
| Net margin | 13.4% | 12.1% | 11.2% | 11.4% | 15.8% | 26.2% | 18.4% | 20.2% | 21.1% | 20.5% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Personal and Healthcare, which carries all its revenue.
Valuation
Today, against the company's own history.Emami PE ratio and valuation
Price to earnings
At or below today's level on 3% of 2,478 trading days over the last 10 years.
LowestHighest
Its median41.55Industry median35.69
Price to book
At or below today's level on 4% of 1,979 trading days since Nov 2018.
LowestHighest
Its median9.19Industry median5.56
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 94% of 2,450 trading days over the last 10 years.
LowestHighest
Its median1.59%Industry median2.41%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −29.6% | −3.9% | −29.4% | 2.5% |
| 3 years | +5.2% | +7.0% | −3.6% | 2.0% |
| 5 years | −2.1% | +11.7% | −14.2% | 2.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Mutual fund holdings
114 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 51 of the 66 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.All 114 funds holding Emami
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 2
- Bought againBought again. Funds that held it at the month's end, had not held it the month before, and held it in an earlier month.
- 1
- AddedAdded. Funds that held more shares than at the end of the month before.
- 24
- CutCut. Funds that held fewer shares than at the end of the month before.
- 42
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 45
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end. Sold out in the glossary
- 9
| Fund | |||
|---|---|---|---|
 Nippon India Small Cap FundNippon India Mutual Fund | 1,68,44,801 | 0.79% | ₹638.5 Cr |
| Nippon India Multi Cap FundNippon India Mutual Fund | 1,19,50,307 | 0.84% | ₹453.0 Cr |
 SBI Large & Midcap FundSBI Mutual Fund | 65,00,000 | 0.61% | ₹246.4 Cr |
 DSP Aggressive Hybrid FundDSP Mutual Fund | 46,79,374 | 1.57% | ₹177.4 Cr |
| DSP ELSS Tax Saver FundDSP Mutual Fund | 43,45,045 | 1.06% | ₹164.7 Cr |
| DSP Large & Mid Cap FundDSP Mutual Fund | 34,36,146 | 0.75% | ₹130.2 Cr |
 HDFC Small Cap FundHDFC Mutual Fund | 33,65,892 | 0.31% | ₹127.6 Cr |
| DSP Flexi Cap FundDSP Mutual Fund | 32,82,517 | 1.06% | ₹124.4 Cr |
 Sundaram Mid Cap FundSundaram Mutual Fund | 29,19,992 | 0.80% | ₹110.7 Cr |
 Bandhan Value FundBandhan Mutual Fund | 25,00,000 | 1.00% | ₹94.8 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 28 Oct 2025.Emami insider trading
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 57 pledge filings of unclear kind
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Emami competitors and peers
Personal Care, 21 listed companies, priced on 27 Oct 2026. The table lists the 8 companies closest to Emami in market cap.FMCG companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Colgate Palmolive (India)COLPAL | 43,610 | 32.02 | 26.96 | +8.7% | +2.7% | 85.1% | 109.0% | 2.99% |
 CupidCUPID | 42,572 | 310.39 | 94.44 | – | – | 34.6% | 30.9% | 0.00% |
 Gillette IndiaGILLETTE | 23,846 | 35.69 | 25.20 | – | – | 67.8% | 93.5% | 3.28% |
 Procter & Gamble Hygiene and Health CarePGHH | 21,960 | 27.77 | 29.14 | – | – | 106.1% | 137.6% | 3.77% |
 Honasa ConsumerHONASA | 14,733 | 59.20 | 10.44 | +21.1% | +237.4% | 19.2% | 18.2% | 0.66% |
 Bajaj Consumer CareBAJAJCON | 5,048 | 20.12 | 5.62 | +28.5% | +83.8% | 32.5% | 31.4% | 0.00% |
 Anondita MedicareANONDITA | 1,928 | 56.23 | – | – | – | 26.5% | – | 0.00% |
 Recode StudiosRECODE | 431 | 38.45 | – | – | – | 56.1% | – | 0.06% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Emami dividend history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up. Dividend per share in the glossaryHighest ₹10.00 a share, years to Mar 2025 and Mar 2026.
| Ex-date | Type | Per share |
|---|---|---|
| 10 Feb 2026 | Interim | ₹6.00 |
| 14 Nov 2025 | Interim | ₹4.00 |
| 22 May 2025 | Special | ₹2.00 |
| 4 Feb 2025 | Interim | ₹4.00 |
| 18 Nov 2024 | Interim | ₹4.00 |
| 16 Feb 2024 | Interim | ₹4.00 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Emami announcements
Oct 2026
26 Oct · Analysts
24 Oct · Updates
13 Oct · Corporate Action-Updates on Buy back
9 Oct · Closure of Buy Back
Emami share price by year
Each calendar year to 2025.Emami share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 528.60 | −12.0% | 646.85 | 506.80 |
| 2024 | 600.75 | +6.6% | 839.75 | 423.05 |
| 2023 | 563.75 | +32.6% | 567.65 | 343.00 |
| 2022 | 425.05 | −18.1% | 521.85 | 400.30 |
| 2021 | 519.00 | +22.5% | 608.20 | 423.70 |
| 2020 | 423.75 | +36.7% | 442.80 | 154.35 |
| 2019 | 309.90 | −26.2% | 439.45 | 267.25 |
| 2018 | 420.10 | −36.8% | 668.20 | 395.10 |
| 2017 | 665.10 | +39.8% | 665.30 | 486.20 |
| 2016 | 475.78 | −4.8% | 623.73 | 456.15 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.
Recent sessions
The 9 trading days to 26 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 26 Oct 2026 | 369.10 | 373.00 | 365.00 | 366.30 | 367.72 | 2,48,474 | 41.7% |
| 23 Oct 2026 | 372.00 | 375.10 | 361.60 | 373.15 | 368.97 | 8,15,209 | 52.5% |
| 22 Oct 2026 | 373.55 | 379.20 | 367.95 | 377.30 | 375.51 | 11,86,128 | 75.1% |
| 21 Oct 2026 | 372.95 | 379.25 | 369.00 | 377.20 | 374.43 | 6,87,073 | 56.8% |
| 19 Oct 2026 | 373.50 | 376.15 | 370.30 | 375.05 | 374.24 | 4,14,526 | 57.5% |
| 16 Oct 2026 | 375.00 | 377.25 | 370.05 | 376.15 | 374.94 | 2,60,327 | 43.7% |
| 15 Oct 2026 | 378.20 | 383.35 | 372.55 | 373.60 | 376.65 | 3,95,610 | 44.9% |
| 14 Oct 2026 | 373.45 | 382.95 | 369.25 | 378.20 | 378.51 | 6,30,738 | 37.1% |
| 13 Oct 2026 | 365.50 | 374.80 | 362.00 | 373.50 | 369.58 | 6,60,614 | 53.0% |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Bonus shares and stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 21 Jun 2018 | Bonus | 0.5000 | Holders received 1 bonus share for every 1 held. |
| 26 Jun 2013 | Bonus | 0.6667 | Holders received 1 bonus share for every 2 held. |
| 21 Jul 2010 | Split | 0.5000 | Each share became 2. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- NSE symbol
- EMAMILTD
- BSE code
- 531162
- ISIN
- INE548C01032
- Industry
- Personal Products
- Website
- www.emamiltd.in
- CIN
- L63993WB1983PLC036030
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1983
- Registered office
- 687, Anandapur E M Bypass, Kolkata 700107, West Bengal
- Share registrar
- Maheshwari Datamatics Pvt Ltd
- Keeps the register of shareholders and handles transfers and dividend payments
In Nifty 500, BSE 500, Nifty Smallcap 250, BSE 250 SmallCap Index, BSE MidCap, Nifty Total Market